Brighton Collaboration
Appearance
![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
![]() Service Mark of the Brighton Collaboration Foundation | |
Formation | 2000 |
---|---|
Type | NPO |
Purpose | Safest, effective vaccines based on rigorous science To enhance the science of vaccine research by providing standardized, validated, and objective methods for continuous monitoring of safety profiles and by assessing benefit-risk ratios. These methods are, in turn, recognized and recommended for use by international regulatory and public health agencies.[1] |
Headquarters | Basel, Switzerland |
Region served | Worldwide |
Official language | English |
Leader | Jan Bonhoeffer, president |
Website | brightoncollaboration.us |
The Brighton Collaboration (BC) is a non-profit global vaccine safety research network for health care professionals, named after the city in England where the idea was first formulated.[citation needed]
The Brighton Collaboration was launched in 2000, although the idea of the collaboration started one year earlier, following a presentation by Bob Chen at an international scientific vaccine conference in Brighton. In his talk, he stressed the need to improve vaccine safety monitoring by developing internationally accepted standards.[2]
References
- ^ "EVI and Brighton Collaboration Foundation (BCF) sign Memorandum of Understanding (MoU)". Archived from the original on 2011-10-31. Retrieved 2012-07-17.
- ^ Chen RT (1999). "Vaccine risks: real, perceived and unknown". Vaccine. 17 Suppl 3: S41-6. doi:10.1016/s0264-410x(99)00292-3. PMID 10559533.